0001645113-21-000076.txt : 20210611 0001645113-21-000076.hdr.sgml : 20210611 20210611162125 ACCESSION NUMBER: 0001645113-21-000076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210609 FILED AS OF DATE: 20210611 DATE AS OF CHANGE: 20210611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HILLEMAN JERYL L CENTRAL INDEX KEY: 0001216628 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 211011568 MAIL ADDRESS: STREET 1: C/O INTERSECT ENT, INC. STREET 2: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_162344285531541.xml FORM 4 X0306 4 2021-06-09 0 0001645113 NovoCure Ltd NVCR 0001216628 HILLEMAN JERYL L C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 1 0 0 0 Restricted Stock Units 2021-06-09 4 A 0 814 0 A 4214 D Ordinary Shares 2021-06-09 4 D 0 1270 210.01 D 2944 D Options to Buy Ordinary Shares 211.89 2021-06-09 4 A 0 1499 0 A 2031-06-09 Ordinary Shares 1499.0 1499 D These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman. Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. By: /s/ Steven Robbins, Attorney in Fact for Jeryl L. Hilleman 2021-06-11